Trial Profile
A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Dusquetide (Primary)
- Indications Stomatitis
- Focus Registrational; Therapeutic Use
- Acronyms DOM-INNATE; DOMINNATE
- Sponsors Soligenix
- 03 Aug 2022 Status changed from active, no longer recruiting to completed.
- 04 Dec 2021 This trial has been completed in Poland, according to European Clinical Trials Database record.
- 08 Oct 2021 This trial has been completed in Belgium and Hungary, according to European Clinical Trials Database record.